Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advances in the clinical management of uveal melanoma
Richard D. Carvajal, Joseph J. Sacco, Martine J. Jager, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 2, pp. 99-115
Closed Access | Times Cited: 136

Showing 1-25 of 136 citing articles:

Antigen presentation in cancer — mechanisms and clinical implications for immunotherapy
Kailin Yang, Ahmed Halima, Timothy A. Chan
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 9, pp. 604-623
Closed Access | Times Cited: 115
Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma
Jessica C. Hassel, Sophie Piperno‐Neumann, Piotr Rutkowski, et al.
New England Journal of Medicine (2023) Vol. 389, Iss. 24, pp. 2256-2266
Open Access | Times Cited: 93
Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Bilan Wang, Shiqi Hu, Yan Teng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 87
A Bioactive Injectable Hydrogel Regulates Tumor Metastasis and Wound Healing for Melanoma via NIR‐Light Triggered Hyperthermia
Xueyi Liu, Meifang Shen, Tiejun Bing, et al.
Advanced Science (2024) Vol. 11, Iss. 26
Open Access | Times Cited: 20
Enantioselective photocatalytic synthesis of bicyclo[2.1.1]hexanes as ortho-disubstituted benzene bioisosteres with improved biological activity
Pablo Garrido-García, Irene Quirós, Paula Milán-Rois, et al.
Nature Chemistry (2025)
Closed Access | Times Cited: 3
Integrated microfluidics-based construction of anti-BTN2A2 gel droplet cell preparations for non-invasive tumor-infiltrating lymphocyte therapy
Yishen Tian, Jingxuan Li, Na Yang, et al.
Materials Today Bio (2025) Vol. 31, pp. 101545-101545
Open Access | Times Cited: 2
Uveal melanoma: In the era of new treatments
Mylène Wespiser, Ève-Marie Neidhardt, Sylvie Négrier
Cancer Treatment Reviews (2023) Vol. 119, pp. 102599-102599
Closed Access | Times Cited: 23
Efficacy and Safety of the Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma: Results from an Open-Label, Single-Arm, Multicenter Phase 3 Study
Jonathan S. Zager, Marlana Orloff, Pier Francesco Ferrucci, et al.
Annals of Surgical Oncology (2024) Vol. 31, Iss. 8, pp. 5340-5351
Open Access | Times Cited: 15
15-Gene Expression Profile and PRAME as Integrated Prognostic Test for Uveal Melanoma: First Report of Collaborative Ocular Oncology Group Study No. 2 (COOG2.1)
J. William Harbour, Zélia M. Corrêa, Amy C. Schefler, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 28, pp. 3319-3329
Open Access | Times Cited: 15
Uveal melanoma: Current evidence on prognosis, treatment and potential developments
Maria C. Gelmi, Martine J. Jager
Asia-Pacific Journal of Ophthalmology (2024) Vol. 13, Iss. 2, pp. 100060-100060
Open Access | Times Cited: 12
Current State of Melanoma Therapy and Next Steps: Battling Therapeutic Resistance
Anna Fateeva, Kevinn Eddy, Suzie Chen
Cancers (2024) Vol. 16, Iss. 8, pp. 1571-1571
Open Access | Times Cited: 12
The potential and promise for clinical application of adoptive T cell therapy in cancer
Yinqi Li, Yeteng Zheng, Taiqing Liu, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 12
Heterogeneity and molecular landscape of melanoma: implications for targeted therapy
Yasaman Zohrab Beigi, Hossein Lanjanian, Reyhane Fayazi, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 11
Uveal melanoma immunogenomics predict immunotherapy resistance and susceptibility
Shravan Leonard‐Murali, Chetana Bhaskarla, Ghanshyam S. Yadav, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Deferral of Treatment for Small Choroidal Melanoma and the Risk of Metastasis: An Investigation Using the Liverpool Uveal Melanoma Prognosticator Online (LUMPO)
Bertil Damato, Antonio Eleuteri, Azzam Taktak, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1607-1607
Open Access | Times Cited: 9
Multifunctional Thermoelectric Nanocatalysts for Synergistic Uveal Melanoma Treatment by Specific Cuproptosis and Pyroptosis
Muyue Yang, Xiaoyan Jiang, Mingyang Song, et al.
Advanced Functional Materials (2025)
Closed Access | Times Cited: 1
Non-Cutaneous Melanoma
Leanne Brown, Kelly Olino
Surgical Oncology Clinics of North America (2025)
Closed Access | Times Cited: 1
Optimizing TIL therapy for uveal melanoma: lessons learned and unlearned from cutaneous melanoma
Shravan Leonard‐Murali, Udai S. Kammula
Immunotherapy (2025), pp. 1-9
Open Access | Times Cited: 1
cGAS‐STING Pathway Activation and Systemic Anti‐Tumor Immunity Induction via Photodynamic Nanoparticles with Potent Toxic Platinum DNA Intercalator Against Uveal Melanoma
Hui Tao, Jia Tan, Hanchen Zhang, et al.
Advanced Science (2023) Vol. 10, Iss. 33
Open Access | Times Cited: 19
Practical guidelines for the management of adverse events of the T cell engager bispecific tebentafusp
Jessica C. Hassel, Carola Berking, Andrea Forschner, et al.
European Journal of Cancer (2023) Vol. 191, pp. 112986-112986
Open Access | Times Cited: 17
Double-layered microneedle patch loaded with bioinspired nano-vaccine for melanoma treatment and wound healing
Zesheng Chen, Zicheng Guo, Tao Hu, et al.
International Journal of Biological Macromolecules (2024) Vol. 262, pp. 129961-129961
Closed Access | Times Cited: 8
A three-arm randomised phase II study of the MEK inhibitor selumetinib alone or in combination with paclitaxel in metastatic uveal melanoma
Joseph J. Sacco, Richard A. Jackson, Pippa Corrie, et al.
European Journal of Cancer (2024) Vol. 202, pp. 114009-114009
Open Access | Times Cited: 8
INPP5A phosphatase is a synthetic lethal target in GNAQ and GNA11-mutant melanomas
Ahmed M.O. Elbatsh, Ali Amin‐Mansour, Anne Haberkorn, et al.
Nature Cancer (2024) Vol. 5, Iss. 3, pp. 481-499
Open Access | Times Cited: 7
AIBI Modified Mesoporous Copper Sulfide Nanocomposites for Efficient Non‐Oxygen Dependent Free Radicals‐Assisted Photothermal Therapy in Uveal Melanoma
Pingping Huang, Lingdan Kong, Feiyu Zhang, et al.
Small (2024) Vol. 20, Iss. 27
Closed Access | Times Cited: 7
Co‐delivery Nano System of MS‐275 and V‐9302 Induces Pyroptosis and Enhances Anti‐Tumor Immunity Against Uveal Melanoma
Hong Ren, Zhenkai Wu, Jia Tan, et al.
Advanced Science (2024) Vol. 11, Iss. 31
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top